88MO T-cell responses induced by an individualized neoantigen specific immune therapy in post (neo)adjuvant patients with triple negative breast cancer

0303 health sciences 03 medical and health sciences
DOI: 10.1016/j.annonc.2020.08.209 Publication Date: 2020-09-22T08:26:10Z